BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that its board of directors voted to change the Company’s name to Ardent Health, Inc., effective June 3, 2025. The updated name aligns the Company’s legal name … [Read more…]
BOSTON–(BUSINESS WIRE)–Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing using the VENTANA® MET (SP44) RxDx assay, now available as an add-on to comprehensive genomic profiling (CGP) test orders for patients with non-squamous non-small cell lung cancer … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Epigenetics Market” report has been added to ResearchAndMarkets.com’s offering. The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029. This report … [Read more…]
Expanded coverage brings access to nearly 200 million Americans ARLINGTON, Va. & REYKJAVIK, Iceland–(BUSINESS WIRE)–#kerecis–Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration, today announced that Cigna, one of the largest health insurers in the United States, now includes Kerecis products in its medical … [Read more…]
Reflects Strategic Alignment with Bitcoin-Focused Growth Plans through Proposed Merger with Nakamoto SALT LAKE CITY–(BUSINESS WIRE)–KindlyMD, Inc. (NASDAQ: NAKA) (NASDAQ: KDLY) (“KindlyMD” or the “Company”), a leading provider of integrated healthcare services, today announced it has changed its ticker from “KDLY” to “NAKA” on the Nasdaq Stock Exchange. The ticker for the Company’s tradable warrants … [Read more…]
ENDEAVOUR unites 21 promising lung cancer specialists with internationally recognized experts to foster collaboration and improve patient outcomes Three-year program aims to promote excellence in research and enhance clinical knowledge At launch event in Madrid participants initiated four collaborative research projects which will be developed under expert guidance MADRID–(BUSINESS WIRE)–The ENDEAVOUR lung cancer program, a … [Read more…]
ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be … [Read more…]
Flatiron’s 2025 ASCO research showcases the power of longitudinal, real-world oncology data and innovative AI-driven methodologies to generate actionable evidence, address health equity, and accelerate progress in cancer care and clinical research. NEW YORK–(BUSINESS WIRE)–Please remove the partners listed under “Real-world (rw) ctDNA testing trends and associated outcomes in patients (pts) with early stage breast … [Read more…]
TORONTO–(BUSINESS WIRE)–dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company“), (TSX: DNTL) Canada’s largest and one of North America’s fastest growing networks of dental practices, announced today the results of its Annual General and Special Meeting of Shareholders (“AGM“) held on Thursday, May 22, 2025. At the AGM, Dentalcorp shareholders voted on the following matters, the full … [Read more…]
Ilana Golant Statement on New White House Report NEW YORK–(BUSINESS WIRE)–#foodallergy–The Food Allergy Fund applauds the release of the Make America Healthy Again report, which provides a roadmap for addressing the childhood chronic disease crisis, and thanks the MAHA Commission for prioritizing bold, science-driven solutions to address the health challenges, such as food allergies, that … [Read more…]
